Brooklyn Bach, NP
Nurse Practitioner · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 3
- Since medical school
- 10 years
- Graduated 2016
Offices
3 locations · UCSF Medical Group Business Services · University of California San Francisco
Looking this up.
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Brooklyn Bach’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$22,349
Medicare paid this office $22,349 for 175 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $7,368 | $119 |
| Long return visit (40+ min) | 49 | $6,327 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $3,170 | $81 |
| New patient visit (60+ min) | 14 | $1,930 | $138 |
| Return visit (30+ min) | 15 | $1,035 | $69 |
See all 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $7,368 | $119 |
| Long return visit (40+ min) | 49 | $6,327 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $3,170 | $81 |
| New patient visit (60+ min) | 14 | $1,930 | $138 |
| Return visit (30+ min) | 15 | $1,035 | $69 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $743 | $68 |
| Short return visit (20+ min) | 13 | $551 | $42 |
Who their Medicare patients are
175 Original Medicare patients in 2024. Average age 79 · Women 59% · Also on Medicaid 27% · Health risk score 2.37. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 37% · Heart failure 36% · Chronic kidney disease 36% · Diabetes 31% · Depression 31% · Atrial fibrillation 30% · Cancer 29% · COPD 23% · Dementia 22% · Stroke 12%.
The office billed $143,617, Medicare allowed $28,697 and paid $22,349; for 237 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 175 | 237 | 79 | 2.37 | $143,617 | $22,349 |
| 2023 | 231 | 298 | 79 | 2.48 | $120,599 | $22,074 |
| 2022 | 209 | 279 | 79 | 1.95 | $70,280 | $17,130 |
| 2021 | 63 | 85 | 71 | 1.65 | $53,980 | $7,501 |
| 2020 | 37 | 42 | 71 | 1.26 | $31,785 | $3,632 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $5,956 | $124 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 61 | $3,887 | $63 |
| Advance care planning, first 30 minutes | 42 | $3,087 | $62 |
| Return visit (30+ min) | 27 | $1,936 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $1,553 | $86 |
| Long return visit (40+ min) | 11 | $1,437 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,372 | $57 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $641 | $46 |
2022: 5 services
| Advance care planning, first 30 minutes | 140 | $10,323 | $63 |
| Advance care planning, each additional 30 minutes | 28 | $1,695 | $57 |
| Return visit (30+ min) | 19 | $1,345 | $71 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,125 | $75 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $606 | $47 |
2021: 1 service
| Long return visit (40+ min) | 38 | $4,674 | $109 |
2020: 2 services
| Long return visit (40+ min) | 18 | $1,839 | $88 |
| Return visit (30+ min) | 13 | $804 | $62 |
Drugs they prescribed that Part D paid
$254,092
Pharmacies billed $254,092 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 545) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
432 generic and 113 brand-name prescriptions · $254,092 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 22 | $212,777 | $9,672 |
| Gavilyte-G | 145 | $2,610 | $18 |
| Sod Sulf-Potass Sulf-Mag Sulf | 20 | $1,369 | $68 |
| Peg-3350 and Electrolytes | 62 | $1,333 | $21 |
| Gavilyte-C | 28 | $499 | $18 |
See all 8 drugs
| Creon | 22 | $212,777 | $9,672 |
| Gavilyte-G | 145 | $2,610 | $18 |
| Sod Sulf-Potass Sulf-Mag Sulf | 20 | $1,369 | $68 |
| Peg-3350 and Electrolytes | 62 | $1,333 | $21 |
| Gavilyte-C | 28 | $499 | $18 |
| Ondansetron | 193 | $359 | $2 |
| Omeprazole | 12 | $112 | $9 |
| Pantoprazole | 13 | $103 | $8 |
Year by year
| 2024 | 545 | 269 | 0% (0) | 21% | $254,092 |
| 2023 | 387 | 186 | 0% (0) | 17% | $232,841 |
| 2022 | 283 | 140 | 0% (0) | 38% | $201,823 |
| 2021 | 249 | 117 | None | 43% | $138,164 |
| 2020 | 172 | 82 | None | None | $44,125 |
| 2019 | 85 | 24 | None | 14% | $4,258 |
| 2018 | 64 | 18 | None | None | $2,470 |
| 2017 | 14 | None | 0% (0) | None | $2,777 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Creon | 30 | $214,522 | $7,151 |
| Gavilyte-G | 132 | $3,065 | $23 |
| Peg-3350 and Electrolytes | 25 | $595 | $24 |
| Ondansetron | 127 | $216 | $2 |
2022: 6 drugs
| Creon | 41 | $185,552 | $4,526 |
| Suprep | 15 | $1,744 | $116 |
| Gavilyte-G | 48 | $847 | $18 |
| Peg-3350 and Electrolytes | 44 | $711 | $16 |
| Omeprazole | 11 | $190 | $17 |
| Ondansetron | 69 | $178 | $3 |
2021: 7 drugs
| Creon | 46 | $127,692 | $2,776 |
| Suprep | 19 | $2,122 | $112 |
| Ursodiol | 13 | $1,539 | $118 |
| Omeprazole | 17 | $432 | $25 |
| Peg-3350 and Electrolytes | 28 | $373 | $13 |
| Gavilyte-G | 30 | $342 | $11 |
| Ondansetron | 43 | $112 | $3 |
2020: 4 drugs
| Gavilyte-G | 25 | $336 | $13 |
| Peg-3350 and Electrolytes | 14 | $200 | $14 |
| Omeprazole | 12 | $155 | $13 |
| Ondansetron | 37 | $77 | $2 |
2019: 1 drug
| Acyclovir | 17 | $834 | $49 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1780077750
- Licence
- MA 2304378, NY 687345, OR 201800724NP-PP
- Group
- UCSF Medical Group Business Services · University of California San Francisco
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LA2100X (363LA2100X); Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 3181 Sw Sam Jackson Park Rd, Portland, OR, 97239
- NPI first listed
- 2015-03-14
- NPI last updated
- 2018-08-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 27 Park St, Hyannis, MA, 02601